RSPO2 and atherosclerosis: Therefore, inhibition of Rspo2-induced LGR4 activation and downstream Wnt signaling utilizing recombinant proteins, blocking antibodies, and small molecule inhibitors has the potential to reduce atherosclerosis; however, this possibility requires further investigation.